Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF

BACKGROUND: The age at which heart failure develops varies widely between countries and drug tolerance and outcomes also vary by age. We have examined the efficacy and safety of LCZ696 according to age in the Prospective comparison of angiotensin receptor neprilysin inhibitor with angiotensin conver...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur Heart J
Hauptverfasser: Jhund, Pardeep S., Fu, Michael, Bayram, Edmundo, Chen, Chen-Huan, Negrusz-Kawecka, Marta, Rosenthal, Arvo, Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J.V., Packer, Milton
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2015
Schlagworte:
Clinical Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4595742/
https://ncbi.nlm.nih.gov/pubmed/26231885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv330
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge